Arthrone

Private

BeijingHealthcare & Life Scienceshttp://arthrone.com/

Last Round

Series C

Extension

Apr 3, 2026

Total Funding Raised

$49.8M

Company Overview

Arthrone is a therapeutic devices company that develops and manufactures orthopaedic medical devices designed to restore joint function and treat musculoskeletal conditions.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Advanced Materials

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Non-AI

Keywords

orthopedic implantsceramic implantsjoint replacementbioceramic technologymedtechhip replacementzirconia femoral headknee replacementmedical device manufacturinghip arthroplastyspine implantsknee arthroplastytotal hip replacementTHRdental implantstotal knee replacementTKRNMPA approval

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Arthrone Comps

Public and private peers based on sector, stage, and business model.

Arthrone comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Arthrone Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Series C Extension	Apr 3, 2026
Series C	Aug 25, 2023
Series B	Mar 10, 2021
Series A	May 21, 2019
Angel	Sep 6, 2017

View all Funding Rounds

Arthrone Investors

Notable investors and investment history

Arthrone investors
Investor	Rounds
Beijing E-Town International Investment & Development Co., Ltd.	Series C Extension
Qianshan Capital Management Co., Ltd.	Series A
Huimei Capital	Series B
CDIB Capital International	Series C
SAIF Partners	Series C
Cowin Capital	Series B
Taihe Capital	Series A

View all Investors

Arthrone Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Arthrone Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Arthrone's valuation, stock price, and market status.

Firmographic Details

HeadquartersBeijing

Employee Range1

Year Founded2017

Last FundingApr 3, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.